Edition:
United States

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

13.80USD
17 Aug 2018
Change (% chg)

$-0.38 (-2.68%)
Prev Close
$14.18
Open
$14.13
Day's High
$14.86
Day's Low
$13.49
Volume
136,069
Avg. Vol
86,286
52-wk High
$30.00
52-wk Low
$12.54

Chart for

About

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The... (more)

Overall

Beta: --
Market Cap(Mil.): $562.82
Shares Outstanding(Mil.): 40.78
Dividend: --
Yield (%): --

Financials

  OPTN.OQ Industry Sector
P/E (TTM): -- 95.67 30.17
EPS (TTM): -2.43 -- --
ROI: -59.61 3.33 12.67
ROE: -- 2.31 14.86

Earnings vs. Estimates